VAERS reports by lot

GSK Varicella/Shingles lot 5NC4N: VAERS reports

31 VAERS reports list lot 5NC4N as a GSK Varicella/Shingles vaccine, received between 2022-10-29 and 2024-05-10. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
0%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1632%
General / Systemic (non-local)1020%
Musculoskeletal816%
Dermatological (non-injection-site)612%
Gastrointestinal48%
Neurological24%
Cardiac / Cardiovascular24%
Allergic / Anaphylactic24%

Where reports came from

U.S. state of the reporter, where given (top 11).

District of Columbia8
Georgia2
Indiana2
Michigan2
Texas1
South Carolina1
Ohio1
Maryland1
Kansas1
West Virginia1
Pennsylvania1

Reports by month received

2022-101
2022-112
2023-016
2023-021
2023-031
2023-041
2023-051
2023-112
2023-128
2024-012
2024-022
2024-031
2024-053

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.